Identification of lead CD24 scFvs for integration into CAR T-cell therapy
CD24 is a heavily glycosylated surface protein reportedly expressed across a broad range of solid and hematological malignancies, making it an attractive candidate antigen for chimeric antigen receptor (CAR) T-cell therapy. Using publicly available datasets, we confirmed that CD24 is broadly expressed across tumor types and, in a single CD19-negative relapse of B-cell acute lymphoblastic leukemia, remained expressed after CD19 CAR T-cell therapy. Thus, CD24 has potential both as a pan-cancer target and as a second-line or combinatorial target following antigen escape. Notably, the antigen recognition domain of the CAR, typically a single chain variable fragment (scFv) of an antibody, is a critical determinant of CAR specificity and function. We here, therefore, performed a head-to-head comparison of four CD24 second-generation 4-1BB CAR T-cells differing only in their scFv clone, specifically clones H2L3, SWA11 and GB7011–05 recognizing the protein core of CD24 and clone SN3 recognizing a CD24 glyco-epitope. The H2L3-derived CAR T-cells displayed high basal IFN-γ production whereas the SWA11-derived CAR T-cells were cytotoxic against cell lines with undetectable CD24 expression. The SN3- and GB7011–05 derived CARs were CD24-specific, and phenotypically equivalent, making them both promising candidates for further exploitation.
Authors
- Maria Lysandrou (ORCID: https://orcid.org/0009-0007-2913-4140)
- Edwin Bremer (ORCID: https://orcid.org/0000-0002-0325-7376)
- Jimena Álvarez Freile (ORCID: https://orcid.org/0000-0003-3146-4345)
- Douwe Freerk Samplonius (ORCID: https://orcid.org/0000-0002-0613-7150)
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fimmu.2026.1989845
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universitair Medisch Centrum Groningen